PSS7 THE COST-EFFECTIVENESS OF RANIBIZUMAB COMPARED TO PDT-VAND BSC FOR THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION IN CANADA
May 1, 2008, 00:00 AM
10.1016/S1098-3015(10)70902-5
https://www.valueinhealthjournal.com/article/S1098-3015(10)70902-5/fulltext
Section Title :
Section Order :
658
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)70902-5&doi=10.1016/S1098-3015(10)70902-5